1. Home
  2. BANX vs MYO Comparison

BANX vs MYO Comparison

Compare BANX & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$20.98

Market Cap

201.5M

Sector

Finance

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.48

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANX
MYO
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.5M
68.9M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
BANX
MYO
Price
$20.98
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
35.3K
411.4K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$18.45
$0.61
52 Week High
$22.50
$1.89

Technical Indicators

Market Signals
Indicator
BANX
MYO
Relative Strength Index (RSI) 56.83 55.98
Support Level $20.62 $0.92
Resistance Level $20.99 $1.89
Average True Range (ATR) 0.26 0.10
MACD -0.03 -0.00
Stochastic Oscillator 50.00 87.04

Price Performance

Historical Comparison
BANX
MYO

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: